BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

Ann: Botanix Announces Cannabidiol Supply Agreement with Purisy, page-103

  1. 2,661 Posts.
    lightbulb Created with Sketch. 160
    On FB today
    apologies if already posted
    getting all our ducks in a row - one of those ducks surely has to be a positive announcement for BTX 1503 Phase 2 study

    Botanix has today announced the execution of a synthetic cannabidiol Supply Agreement with Purisys – the world’s leading and most advanced synthetic cannabinoid manufacturer.

    This agreement will provide for immediate clinical and future commercial supplies of synthetic cannabidiol and comes with pricing preferences and exclusivity in our target skin disease areas.

    We’re getting all our ducks in a row, as we fast approach critical milestones in the Botanix Pharmaceuticals clinical research program, including highly anticipated data from the BTX 1503 Phase 2 study (coming soon).

    Read our ASX announcement here http://bit.ly/BOT_Purisys

    No photo description available.



 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.010(2.63%)
Mkt cap ! $669.7M
Open High Low Value Volume
38.0¢ 38.5¢ 36.5¢ $2.548M 6.766M

Buyers (Bids)

No. Vol. Price($)
2 96148 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 782479 9
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.